For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241111:nRSK6141La&default-theme=true
RNS Number : 6141L Spire Healthcare Group PLC 11 November 2024
11 November 2024
Spire Healthcare Group plc
Transaction in own shares
Spire Healthcare Group plc (the "Company") announces that, in accordance with
the terms of its share buyback programme announced on 31 October 2024 (the
"Share Buyback Programme") and the authority granted by its shareholders at
the Company's 2024 Annual General Meeting held on 9 May 2024, it has purchased
the following number of its ordinary shares of 1 pence each ("Shares") on the
London Stock Exchange through Numis Securities Limited ("Deutsche Numis"):
Date of purchase: 8 November 2024
Number of Shares purchased: 70,000
Highest price paid per Share (GBp): 217.00
Lowest price paid per Share (GBp): 214.50
Volume weighted average price paid per Share (GBp): 215.0810
Broker: Deutsche Numis
Trading venue: London Stock Exchange
The purchased Shares will be cancelled.
Following the purchase of these Shares, the remaining number of Shares in
issue will be 403,818,352. The Company does not hold any Shares in treasury.
Therefore, the total number of voting rights in the Company is 403,818,352.
This figure may be used by shareholders as the denominator for the calculation
by which they can determine if they are required to notify their interest in,
or a change to their interest in, the Company under the FCA's Disclosure
Guidance and Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it forms
part of domestic law of the United Kingdom by virtue of the European Union
(Withdrawal) Act 2018, the table below contains detailed information of the
individual trades made by Deutsche Numis as part of the Share Buyback
Programme:
Date of purchase Number of ordinary shares purchased Transaction price (GBp share) Time of transaction (UK Time) Transaction reference number Trading venue
8 November 2024 22 216.00 08:12:44 00072304164TRLO0 XLON
8 November 2024 450 216.00 08:12:44 00072304163TRLO0 XLON
8 November 2024 9 216.00 08:16:14 00072304451TRLO0 XLON
8 November 2024 2170 216.00 09:14:26 00072308195TRLO0 XLON
8 November 2024 1727 215.00 09:40:52 00072310050TRLO0 XLON
8 November 2024 507 215.00 09:40:52 00072310049TRLO0 XLON
8 November 2024 1803 215.00 10:06:36 00072311707TRLO0 XLON
8 November 2024 182 215.00 10:06:36 00072311706TRLO0 XLON
8 November 2024 582 215.00 10:42:32 00072313496TRLO0 XLON
8 November 2024 2065 215.00 10:42:32 00072313495TRLO0 XLON
8 November 2024 1375 215.00 10:42:32 00072313494TRLO0 XLON
8 November 2024 936 215.00 10:42:36 00072313498TRLO0 XLON
8 November 2024 1200 215.00 10:42:36 00072313497TRLO0 XLON
8 November 2024 817 215.00 10:42:36 00072313500TRLO0 XLON
8 November 2024 1200 215.00 10:42:36 00072313499TRLO0 XLON
8 November 2024 702 215.00 10:42:37 00072313502TRLO0 XLON
8 November 2024 1200 215.00 10:42:37 00072313501TRLO0 XLON
8 November 2024 402 215.00 10:45:14 00072313562TRLO0 XLON
8 November 2024 700 215.00 10:45:14 00072313561TRLO0 XLON
8 November 2024 769 215.00 10:45:14 00072313560TRLO0 XLON
8 November 2024 1465 214.50 11:32:31 00072315615TRLO0 XLON
8 November 2024 527 214.50 11:32:31 00072315614TRLO0 XLON
8 November 2024 643 214.50 11:32:31 00072315613TRLO0 XLON
8 November 2024 826 214.50 11:32:31 00072315612TRLO0 XLON
8 November 2024 900 214.50 11:32:31 00072315611TRLO0 XLON
8 November 2024 73 214.50 11:32:31 00072315610TRLO0 XLON
8 November 2024 490 215.00 12:02:04 00072316547TRLO0 XLON
8 November 2024 112 215.00 12:02:04 00072316546TRLO0 XLON
8 November 2024 1800 215.00 12:02:04 00072316545TRLO0 XLON
8 November 2024 14033 214.50 12:03:38 00072316621TRLO0 XLON
8 November 2024 16000 214.50 12:03:56 00072316647TRLO0 XLON
8 November 2024 280 216.00 12:18:30 00072317219TRLO0 XLON
8 November 2024 844 216.00 12:18:30 00072317218TRLO0 XLON
8 November 2024 1131 216.00 12:18:30 00072317217TRLO0 XLON
8 November 2024 93 216.00 12:33:03 00072317845TRLO0 XLON
8 November 2024 1958 216.00 12:33:03 00072317844TRLO0 XLON
8 November 2024 798 217.00 14:07:01 00072321571TRLO0 XLON
8 November 2024 620 217.00 14:07:01 00072321570TRLO0 XLON
8 November 2024 442 217.00 14:07:01 00072321569TRLO0 XLON
8 November 2024 145 217.00 14:28:01 00072322896TRLO0 XLON
8 November 2024 653 217.00 14:28:01 00072322895TRLO0 XLON
8 November 2024 393 217.00 14:28:01 00072322894TRLO0 XLON
8 November 2024 709 217.00 14:28:01 00072322893TRLO0 XLON
8 November 2024 2075 217.00 14:45:25 00072324190TRLO0 XLON
8 November 2024 208 216.50 15:18:11 00072327491TRLO0 XLON
8 November 2024 957 216.00 15:31:48 00072328867TRLO0 XLON
8 November 2024 58 216.00 15:31:48 00072328868TRLO0 XLON
8 November 2024 114 216.00 15:31:48 00072328869TRLO0 XLON
8 November 2024 674 216.00 15:31:48 00072328870TRLO0 XLON
8 November 2024 2161 216.00 16:11:21 00072332260TRLO0 XLON
This announcement will also be available on the Company's website at:
https://investors.spirehealthcare.com/news/regulatory-news/
Enquiries:
Spire Healthcare
Harbant Samra, CFO
+44 (0)7881 672 365
Instinctif Partners
Julian
Walker
+44 (0)7825 189 696
Registered Office and Head Office:
Spire Healthcare Group plc
3 Dorset Rise
London
EC4Y 8EN
Registered number 09084066
About Spire Healthcare
Spire Healthcare (http://www.spirehealthcare.com/) is a leading independent
healthcare group in the United Kingdom, running 38 hospitals and over 50
clinics, medical centres and consulting rooms across England, Wales and
Scotland. It operates a network of private GPs and provides occupational
health services to over 800 corporate clients.
Working in partnership with over 8,600 experienced consultants, Spire
Healthcare delivered tailored, personalised care to over 1 million inpatients,
outpatients and daycase patients, and occupational health programme clients,
in 2023, and is the leading private provider, by volume, of knee
(https://www.spirehealthcare.com/treatments/bones-and-joints/knee-replacement/)
and hip
(https://www.spirehealthcare.com/treatments/bones-and-joints/hip-replacement-surgery/)
operations in the United Kingdom. It also delivers a range of private and NHS
mental health, musculoskeletal and dermatological services under the Vita
Health Group brand.
Spire Healthcare's well-located and scalable hospitals have delivered
successful and award-winning outcomes, positioning the group well with
patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI')
providers. 98% of Spire Healthcare's inspected locations are rated 'Good',
'Outstanding' or the equivalent by health inspectors in England, Wales and
Scotland.
Spire Healthcare is listed on the London Stock Exchange and is a member of the
FTSE 250.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSKBLBFZFLEFBZ